NRSNW NeuroSense Therapeutics Ltd.

Fundamentals / CIK 0001875091 / USD
Other share classes on CIK 0001875091: NRSN

NeuroSense Therapeutics Ltd. reported $1.03M in total assets and a net loss of $11.12M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NRSNW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$10.40MFY 2019 Net Income: -$1.22M2019FY 2020 Net Income: -$2.83M2020FY 2021 Net Income: -$4.04M2021FY 2022 Net Income: -$10.49M2022FY 2023 Net Income: -$10.11M2023FY 2024 Net Income: -$10.21M2024FY 2025 Net Income: -$11.12M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $6.23M $5.70M $7.27M $5.59M -- -- --
Operating Income -$11.09M -$9.90M -$12.05M -$10.55M -$5.59M -$2.89M -$1.24M
EBITDA -$11.07M -$9.88M -$12.03M -$10.54M -$5.58M -$2.88M --
Interest Income -- -- $4.23M $1.26M $2.73M $61K $18K
Interest Expense -- -- $2.21M $45K $1.19M $1.0K $5.0K
Net Income -$11.12M -$10.21M -$10.11M -$10.49M -$4.04M -$2.83M -$1.22M
Basic EPS -$0.44 -$0.54 -$0.74 -$0.91 -$0.65 -$0.51 -$0.26
Diluted EPS -$0.44 -$0.54 -$0.74 -$0.91 -$0.65 -$0.51 --
Basic Shares Outstanding 25.5M 18.6M 13.6M 11.5M -- -- --
Diluted Shares Outstanding 25.5M 18.6M 13.6M 11.5M -- -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for NRSNW.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $166K $3.38M $2.64M $3.54M $11.06M $699K
Cash & Short-Term Investments $166K $3.38M $2.64M $3.54M $11.06M $699K
Accounts Receivable, Net -- -- $236K $255K $310K $30K
Total Current Assets $778K $4.40M $2.92M $7.38M $11.41M $766K
Property, Plant & Equipment, Net $58K $66K $85K $77K $19K $13K
Total Non-Current Assets $250K $173K $269K $329K $19K $13K
Total Assets $1.03M $4.58M $3.19M $7.71M $11.43M $779K
Accounts Payable $799K $1.16M $1.46M $498K $39K $55K
Other Current Liabilities $1.72M $832K $2.00M -- -- --
Total Current Liabilities $2.52M $1.99M $3.46M $1.73M $597K $120K
Total Non-Current Liabilities $72K $0 $1.49M $365K $1.83M $0
Total Liabilities $2.59M $1.99M $4.94M $2.09M $2.42M $120K
Total Debt (incl. Leases) $170K $73K $69K $294K -- --
Retained Earnings -$47.78M -$36.66M -$26.12M -$20.79M -$8.45M -$4.41M
Total Stockholders' Equity -$1.56M $2.58M -$1.76M $5.84M $10.83M $659K
Total Equity -$1.56M $2.58M -$1.76M $5.84M $10.83M $659K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Cash & Cash Equivalents $166K $3.38M $2.64M $3.54M $11.06M $699K
Cash & Short-Term Investments $166K $3.38M $2.64M $3.54M $11.06M $699K
Accounts Receivable, Net -- -- $236K $255K $310K $30K
Total Current Assets $778K $4.40M $2.92M $7.38M $11.41M $766K
Property, Plant & Equipment, Net $58K $66K $85K $77K $19K $13K
Total Non-Current Assets $250K $173K $269K $329K $19K $13K
Total Assets $1.03M $4.58M $3.19M $7.71M $11.43M $779K
Accounts Payable $799K $1.16M $1.46M $498K $39K $55K
Other Current Liabilities $1.72M $832K $2.00M -- -- --
Total Current Liabilities $2.52M $1.99M $3.46M $1.73M $597K $120K
Total Non-Current Liabilities $72K $0 $1.49M $365K $1.83M $0
Total Liabilities $2.59M $1.99M $4.94M $2.09M $2.42M $120K
Total Debt (incl. Leases) $170K $73K $69K $294K -- --
Retained Earnings -$47.78M -$36.66M -$26.12M -$20.79M -$8.45M -$4.41M
Total Stockholders' Equity -$1.56M $2.58M -$1.76M $5.84M $10.83M $659K
Total Equity -$1.56M $2.58M -$1.76M $5.84M $10.83M $659K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.12M -$10.21M -$10.11M -$10.49M -$4.04M -$2.83M -$1.22M
Depreciation & Amortization $16K $22K $21K $12K $3.0K $3.0K --
Stock-Based Compensation $2.14M $557K $1.54M $1.73M $4.16M $2.06M $611K
Change in Payables -$361K -$299K $961K $459K -$16K $32K $23K
Operating Cash Flow -$7.67M -$10.13M -$8.35M -$7.62M -$1.54M -$695K -$582K
Capital Expenditure -$8.0K -$3.0K -$29K -$70K -$17K -$9.0K -$7.0K
Free Cash Flow -$7.68M -$10.14M -$8.38M -$7.69M -$1.56M -$704K -$589K
Investing Cash Flow -$8.0K $1.0K $3.47M -$3.59M -$17K -$9.0K -$26K
Common Stock Issued $7.0K -- $3.97M -- $9.86M $508K $1.42M
Dividends Paid -- -- -$310K -$310K -$29K -$28K -$27K
Financing Cash Flow $4.43M $10.91M $3.98M $3.77M $11.90M $508K $1.42M
Net Change in Cash -- -- -$903K -$7.52M $10.36M -$196K $809K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for NRSNW.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -395.3% -- -179.5% -37.3% -429.1% --
Return on Assets (ROA) -1082.2% -223.2% -317.3% -136.1% -35.4% -363.0% --
Current Ratio 0.31x 2.21x 0.84x 4.28x 19.12x 6.38x --
Quick Ratio 0.07x 1.70x 0.83x 2.20x 19.05x 6.08x --
Debt to Equity -- 0.03x -- 0.05x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for NRSNW.
Source: SEC EDGAR CompanyFacts (CIK 0001875091) · from December 31, 2019 Data through December 31, 2025 · synced Nov 21, 2026, 05:10 UTC · Open in terminal